IP6K1−/− mice can avoid weight gain and insulin resistance caused by high-fat feeding, owing to the activation of the AKT pathway, therefore inhibition of IP6K1 can be used as a strategy for the treatment of obesity and diabetes (Chakraborty et al., 2010). Here, IP6K1 is linked to obesity disorder.